# Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia

> **NCT07673302** · NA · RECRUITING · sponsor: **Riphah International University** · enrollment: 240 (estimated)

## Conditions studied

- Thalassemia

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** Hydroxy Urea

## Key facts

- **NCT ID:** NCT07673302
- **Lead sponsor:** Riphah International University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-20
- **Primary completion:** 2027-06-19
- **Final completion:** 2027-06-19
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673302, "Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*